A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With Chronic Idiopathic Cough
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of XEN-D0501 over placebo in
reducing the daytime cough frequency in patients with chronic idiopathic cough.
The effectiveness of XEN-D0501 over placebo in reducing capsaicin cough responses, objective
24-hour cough frequency, hourly change in cough frequency, cough severity (via visual
analogue scale [VAS]), urge to cough (via VAS), global rating of change scale and Leicester
Cough Questionnaire (LCQ) will be evaluated.